🇺🇸 FDA
Patent

US 8383093

Subcutaneous delivery of poly(oxazoline) conjugates

granted A61KA61K31/381A61K31/4045

Quick answer

US patent 8383093 (Subcutaneous delivery of poly(oxazoline) conjugates) held by Serina Therapeutics, Inc. expires Mon Feb 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Serina Therapeutics, Inc.
Grant date
Tue Feb 26 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K31/381, A61K31/4045, A61K31/4462, A61K31/4535